MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Subacute Severe Dystonia in a 19-month Old Boy. A Case of Pediatric Stiff Person Syndrome (SPS)

MU. Huun, S. Wallace, SH. Nordstrand (Oslo, Norway)

Meeting: 2025 International Congress

Keywords: Dopamine, Dystonia: Clinical features, Immunosuppression

Category: Dystonia: Disease Mechanisms / Neuroimaging / Neurophysiology

Objective: To report a rare case of anti-GAD associated encephalitis with pediatric Stiff Person Syndrome (SPS) highlighting the need for broad investigations and extensive treatment.

Background: Anti-GAD-associated encephalitis is exceedingly rare in the pediatric population. Anti-GAD antibodies target glutamic acid decarboxylase, essential for GABAergic neurotransmission, and are also implicated in autoimmune diabetes mellitus.

Method: A 19-month-old boy presented with dystonia with elevated CK, hyperreflexia, and behavioral changes. Initial treatment with levodopa improved ambulatory function, suggesting involvement of dopamine metabolism. Diagnostic testing revealed markedly elevated anti-GAD antibody titers in both blood (> 100 times normal) and cerebrospinal fluid (> 10 times normal). Clinical, EEG and CSF findings (positive anti-GAD, 9 cells and 15 oligoclonal bands) supported diagnosis of autoimmune limbic encephalitis with SPS. MRI was normal twice. Complete metabolic screening, neurotransmitters in CSF and exome sequencing for neurotransmitter and metabolic diseases were negative. Treatment included intravenous immunoglobulin (IVIG), high-dose steroids, plasma exchange, and subsequent rituximab administration to address persistent behavioral and language difficulties.

Results: IVIG and steroids had little effect. Plasma exchange was associated with gradual improvement of motor function and recovery. One year later, rituximab was initiated. Two weeks after the first infusion, however, the child developed diabetic ketoacidosis, underscoring the link between anti-GAD antibodies and autoimmune diabetes. At age four, he was diagnosed with autism spectrum disorder, with behavior more affected than language.

Conclusion: Acute dystonia is a rare presentation at this age and warrants a broad and timely investigation. Aggressive and early intervention led to a clear improvement in motor function, however he developed persistent behavioral and metabolic (diabetic) complications associated with anti-GAD.

To cite this abstract in AMA style:

MU. Huun, S. Wallace, SH. Nordstrand. Subacute Severe Dystonia in a 19-month Old Boy. A Case of Pediatric Stiff Person Syndrome (SPS) [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/subacute-severe-dystonia-in-a-19-month-old-boy-a-case-of-pediatric-stiff-person-syndrome-sps/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/subacute-severe-dystonia-in-a-19-month-old-boy-a-case-of-pediatric-stiff-person-syndrome-sps/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley